Interest Income Expense - West Pharmaceutical Services Inc (NYSE:WST) - Alpha Spread

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 297.24 USD -1.02% Market Closed
Market Cap: 22B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Interest Income Expense Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Interest Income Expense
$9.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Interest Income Expense
-$329m
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
0%
Danaher Corp
NYSE:DHR
Interest Income Expense
-$241m
CAGR 3-Years
-66%
CAGR 5-Years
-38%
CAGR 10-Years
-8%
Mettler-Toledo International Inc
NYSE:MTD
Interest Income Expense
-$78.1m
CAGR 3-Years
-26%
CAGR 5-Years
-17%
CAGR 10-Years
-13%
Agilent Technologies Inc
NYSE:A
Interest Income Expense
-$29m
CAGR 3-Years
28%
CAGR 5-Years
10%
CAGR 10-Years
13%
IQVIA Holdings Inc
NYSE:IQV
Interest Income Expense
-$642m
CAGR 3-Years
-18%
CAGR 5-Years
-9%
CAGR 10-Years
-20%

See Also

What is West Pharmaceutical Services Inc's Interest Income Expense?
Interest Income Expense
9.5m USD

Based on the financial report for Jun 30, 2024, West Pharmaceutical Services Inc's Interest Income Expense amounts to 9.5m USD.

What is West Pharmaceutical Services Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
48%

Over the last year, the Interest Income Expense growth was 48%.

Back to Top